SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-003894
Filing Date
2021-11-10
Accepted
2021-11-10 07:03:39
Documents
79
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q verv-20210930.htm   iXBRL 10-Q 3198646
2 EX-10.1 verv-ex10_1.htm EX-10.1 492836
3 EX-31.1 verv-ex31_1.htm EX-31.1 17827
4 EX-31.2 verv-ex31_2.htm EX-31.2 17827
5 EX-32.1 verv-ex32_1.htm EX-32.1 11618
6 EX-32.2 verv-ex32_2.htm EX-32.2 11617
7 GRAPHIC img155831825_1.jpg GRAPHIC 23714
8 GRAPHIC img155831825_0.jpg GRAPHIC 23714
  Complete submission text file 0000950170-21-003894.txt   10398218

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT verv-20210930_cal.xml EX-101.CAL 45137
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT verv-20210930_def.xml EX-101.DEF 217467
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT verv-20210930.xsd EX-101.SCH 58030
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT verv-20210930_lab.xml EX-101.LAB 460575
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT verv-20210930_pre.xml EX-101.PRE 350429
14 EXTRACTED XBRL INSTANCE DOCUMENT verv-20210930_htm.xml XML 1669450
Mailing Address 500 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 (978) 501-3026
Verve Therapeutics, Inc. (Filer) CIK: 0001840574 (see all company filings)

IRS No.: 824800132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40489 | Film No.: 211394352
SIC: 2834 Pharmaceutical Preparations